Viloxazine and the Depressed Schizophrenic—Methodological Issues

The Journal of Clinical Pharmacology

Volumn 21, Issue 1, 1981, Pages 37-41

  KURLAND, ALBERT A ^a   NAGARAJU, ARRAMRAJU ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CHLORPROMAZINE; HALOPERIDOL; IMIPRAMINE; PLACEBO; VILOXAZINE;

CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG THERAPY; ORAL DRUG ADMINISTRATION; SCHIZOPHRENIA; THERAPY;

EID: 0019420212     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1981.tb01730.x     Document Type: Article

References (30)

1. Symptom patterns in primary and secondary depression
2. Family history studies. VIII. Secondary depression is alive and well
3. The efficacy of antidepressant drugs. A review of research (1958 to 1972)
4. Use of antidepressant drugs in schizophrenia
5. Postpsychotic depression in schizophrenia
6. The utility of psychotropic drug combinations
7. Animal pharmacology of viloxazine (Vivalan)
8. 2‐(2‐Ethoxyphenoxymethyl)tetrahydro‐1,4‐oxazine hydrochloride, a potential psychotropic agent
9. A safer antidepressant?
10. Inhibition of serotonin reuptake
11. Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness
12. Review of the pharmacology of existing antidepressants
13. Blood level studies with viloxazine hydrochloride in man
14. The disposition and metabolism of ICI 58,834 (viloxazine) in humans
15. Non‐metabolite residues of ICI 58,834 (viloxazine). Studies with (14C) morpholine (14C), ethanolamine and (14C) glyoxylate
16. Viloxazine: assessment of potential rapid antidepressant action
17. Clinical profile and serum concentration of viloxazine as compared to amitriptyline
18. A comparative study of viloxazine and imipramine
19. Short‐term effects of viloxazine (Vivalan) compared with a placebo in depression: a double‐blind study
20. A controlled multicentre therapeutic trial of viloxazine
21. The treatment of depressive states with G 22355 (imipramine hydrochloride)
22. The comparative effectiveness of amitriptyline, perphenizine and their combination in the treatment of chronic psychotic female patients
23. Chlorpromazine‐imipramine treatment of newly‐hospitalized acutely ill psychiatric patients
24. Akinetic depression in schizophrenia
25. The pseudoanergic syndrome in somatic manifestations of depressive disorders.
26. Anhedonia and depression in schizophrenia
27. The problem of postpsychotic schizophrenic depressions and their pharmacological induction
28. Treatment of secondary depression in schizophrenia: a double blind placebo‐controlled trial of amitriptyline added to perphenazine
29. Symptom patterns in primary and secondary depression